Wedbush Upgrades Travere Therapeutics (TVTX) to Outperform

February 21, 2023 6:41 AM EST Send to a Friend
Wedbush analyst Laura Chico upgraded Travere Therapeutics (NASDAQ: TVTX) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login